Among the more stable stocks that have been more volatile than usual this year, CVS Health (NYSE: CVS ) is clearly seeing this volatility play out again today. Shares of CVS stock surged 4% in afterno
CVS Health (CVS) shares jumped about 4% Tuesday after the drugstore chain and health-care firm posted strong guidance and raised its dividend on reported higher demand for its health-care services.
Karen Lynch, CVS Health CEO, and CNBC's Bertha Coombs join 'The Exchange' to discuss the company's investor day, prescription drug pricing, and more.
Dr. Scott Gottlieb, former FDA commissioner, joins 'The Exchange' to discuss CVS Health's drug pricing, the role of AI in medicine, and more.
Pharmacy giant CVS Health on Tuesday announced an overhaul of its drug-pricing model to boost transparency amid scrutiny of the soaring cost for medications.
CVS's new effort aims to do away with a complex model that typically determines how much pharmacies get reimbursed and how much patients pay for medications.
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Drugstore chain CVS guided fiscal 2024 revenue higher than expected, and raised the quarterly dividend by 10%.
CVS Health Inc.'s stock CVS, rose 3% premarket Tuesday, after the drug-store chain backed guidance for 2023 and set guidance for 2024 with revenue that's comfortably above consensus. The company said
CVS Health is rebranding its healthcare services operations under a new name, “CVS Healthspire.”

Final Trades: Morgan Stanley, CVS & more

02:20pm, Monday, 04'th Dec 2023
The "Halftime Report" traders give their top picks to watch for the second half.
In many, if not most cases, you want to avoid betting on the same horse, which makes the concept of hidden-gem stocks quite compelling. Generally, the equities sector features at least moderate effici
CVS Health's (CVS) Health Care Benefits segment demonstrates value to consumers and clients by successfully managing drug cost trends and bringing innovative clinical solutions to the market.
Shares in CVS Group (AIM:CVSG) were little moved by its trading update, with analysts saying there was little new news, as the big news remains the ongoing Competition and Markets Authority review

Is it time to buy this market-beaten growth stock?

05:31am, Wednesday, 29'th Nov 2023
Investing is a complex game, but the aim is simple: Profit. Despite there being numerous avenues through which this objective can be achieved, many concentrate on short-term price movement and growth.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE